𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells

✍ Scribed by Klaus A. Becker; Janet L. Stein; Jane B. Lian; Andre J. van Wijnen; Gary S. Stein


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
562 KB
Volume
210
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Rapid self‐renewal of human embryonic stem (ES) cells (NIH designation WA01 and WA09) is accommodated by an abbreviated cell cycle due to a reduction in the G1 phase. Thus, molecular mechanisms operative in ES cells may expedite the cellular commitment to progress into S phase to initiate replication of DNA and biosynthesis of histone proteins to form new chromatin. Here we show that the selective cell cycle regulated expression of individual histone H4 gene copies, which is typical for somatic cell types, is already firmly established in human ES cells. This early establishment of H4 gene regulation, which is E2F independent, is consistent with co‐expression of the cognate transcriptional regulators HiNF‐P and p220^NPAT^. Human ES cells differ from somatic cells in the expression of members of the E2F family and RB‐related pocket proteins (p105^RB1^, p107^RBL1^, and p130^RBL2/RB2^) that control expression of genes encoding enzymes for nucleotide metabolism and DNA synthesis. Human ES cells rapidly and robustly (>200‐fold) induce the cyclin dependent kinase (CDK) inhibitor p21^WAF1/CIP1^ upon gamma‐irradiation. This DNA damage response promptly reduces histone gene expression as well as mRNA levels for HiNF‐P and p220^NPAT^ and causes accumulation of unprocessed histone H4 precursor RNAs. Furthermore, while E2F4, E2F5 and p130^RBL2/RB2^ are the major E2F and pocket protein mRNAs in actively proliferating ES cells, expression levels of E2F5, E2F6, and p105^RB1^ are most strongly elevated during cell cycle arrest in cells responding to DNA damage. Our data suggest that the brief G1 phase of ES cells is supported by a potent p21^WAF1/CIP1^ related DNA damage response that functions through several mechanisms to rapidly inhibit cell cycle progression. This response may alter the E2F/pocket protein combinations that control E2F dependent genes and block H4 gene expression by inhibiting histone‐specific transcription factors and processing of histone gene transcripts, as well as by destabilizing histone mRNAs. J. Cell. Physiol. 210: 517–526, 2007. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Cell cycle dependent phosphorylation and
✍ Prachi N. Ghule; Klaus A. Becker; J. Wade Harper; Jane B. Lian; Janet L. Stein; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract Human embryonic stem (ES) cells have an expedited cell cycle (∼15 h) due to an abbreviated G1 phase (∼2.5 h) relative to somatic cells. One principal regulatory event during cell cycle progression is the G1/S phase induction of histone biosynthesis to package newly replicated DNA. In so

An embryonic story: analysis of the gene
✍ Pablo Navarro; Philip Avner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Corrigendum 1, regarding Figure 1 of the published article: in panel B, the position of the label ''Ctcf'' is not properly aligned. The figure should appear as follows: Corrigendum 2, regarding Figure 2 of the published article: in the figure key, the denotation of the line-symbol indicating repress

The subnuclear organization of histone g
✍ Prachi N. Ghule; Zbigniew Dominski; Jane B. Lian; Janet L. Stein; Andre J. van W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## Abstract Human histone gene expression is controlled at the level of transcription initiation and subsequent 3′end processing to generate non‐polyadenylated stem‐loop containing histone mRNAs. Transcription is controlled at the G1/S phase transition by the Cyclin E/CDK2 mediated induction of p22

Generation of human embryonic stem cell-
✍ Sylvia Niebruegge; Céline L. Bauwens; Raheem Peerani; Nimalan Thavandiran; Steph 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 1017 KB

## Abstract The ability to generate human pluripotent stem cell‐derived cell types at sufficiently high numbers and in a reproducible manner is fundamental for clinical and biopharmaceutical applications. Current experimental methods for the differentiation of pluripotent cells such as human embryo